Home   Web Events   Upcoming Events   MS Info   Message Board   MS News   Links

Multiple Sclerosis - Phase II Study Of Oral Compound BG-12 Meets Primary Endpoint Medical News Today Sun, 29 Jan 2006 4:18 PM PST Biogen Idec (NASDAQ: BIIB) and Fumapharm AG announced that a Phase II study designed to evaluate the efficacy and safety of BG-12, an oral fumarate, in patients with relapsing-remitting multiple sclerosis (MS) met its primary endpoint. Treatment with BG-12 led to a statistically significant reduction in the total number of gadolinium-enhancing brain lesions as measured by MRI with six months of Read more Prompting Neurons to Protect Themselves A team of American and Japanese scientists has found a way to induce nerve cells in the brain and spinal cord to release natural antioxidants that protect the cells from the damage that stress and free radicals can cause. The finding may help in the development of new treatments for stroke, Alzheimer's disease, multiple sclerosis, and other neurodegenerative disorders Read more	Recent News Articles	Newsletters Broadcast News From HealthTalk - Multiple Sclerosis - 01/2007 Broadcast News From HealthTalk - Multiple Sclerosis - 12/2006 Broadcast News From HealthTalk - Multiple Sclerosis - 08/2006 Avonex Newsletter - Summer 2006 New Studies   New Multiple Sclerosis Treatment Reduces Relapse Rate By 90%   Study With Mice Shows Statin and MS Drug May Prevent Paralysis From Multiple Sclerosis   Natalizumab May Be Effective for Multiple Sclerosis   Statin Drugs: Not Just for Heart Disease? Are There Risks of Taking MS Drugs While Pregnant? Women with multiple sclerosis (MS) have generally been advised to stop taking their medications prior to conceiving a child and throughout pregnancy. However, for the first time, studies give a glimpse into what the risks of these drugs may be. Gulf War veterans being diagnosed with Multiple Sclerosis   American and British soldiers received vaccines containing 33 toxins including anthrax, squalene, organophosphorous pesticides, and pyridostigmine bromide . They also received nerve agent tablets. Statistical data kept since the war shows that the American and British soldiers are five (5) to eighteen (18) times more likely to suffer from auto-immune disease than the general public. The French soldiers who did not receive these vaccines have not had any increase in these conditions. Read more and more